Chemistry, biology, and QSAR studies of substituted biaryl hydroxamates and mercaptoacetamides as HDAC inhibitors - Nanomolar-potency inhibitors of pancreatic cancer cell growth

Alan P. Kozikowski, Yufeng Chen, Arsen M. Gaysin, Doris N. Savoy, Daniel D. Billadeau, Ki Hwan Kim

Research output: Contribution to journal › Article › peer-review

55 Scopus citations

Fingerprint

Dive into the research topics of 'Chemistry, biology, and QSAR studies of substituted biaryl hydroxamates and mercaptoacetamides as HDAC inhibitors - Nanomolar-potency inhibitors of pancreatic cancer cell growth'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds